Sun Pharma: How a small Kolkata trader became a global buyout artist

Sun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continues Shanghvi's proven strategy of acquiring companies to fuel growth and global expansion. His approach prioritizes strategic advantage and turnaround potential, as seen in past landmark deals like Ranbaxy and Taro.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fX9BkGL
via IFTTT

Read More

Robotic joint replacement surgery and insurance: The gap patients should know about

Robotic surgery offers better outcomes for knee pain patients. However, many Indians cannot access this advanced treatment due to insurance limitations. Insurers should update policies to cover robotic procedures equally with traditional ones. This will improve patient recovery and reduce long-term healthcare costs. Aligning insurance with medical progress ensures better healthcare for everyone.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rM0dKRt
via IFTTT

Read More

ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwide

Cyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide affordable vaccines and save lives. The institute has since become a global leader, supplying vaccines to over 100 countries. It played a crucial role during the Covid-19 pandemic. Poonawalla hopes his son Adar will continue this mission.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wuhJGK2
via IFTTT

Read More

Sun Pharma to buy Organon in $11.75 billion all-cash deal

Sun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion, including debt. The agreement stipulates Sun Pharma will purchase all outstanding Organon shares for $14.00 per share. This acquisition will grant Sun Pharma full ownership of Organon, a company focused on women's health, biosimilars, and established medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/d54ys7m
via IFTTT

Read More

ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till date

US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai HQed company pips the consortium of EQT-Gruenthal. Sun will pay $4.5 billion for Organon’s equity and inherit $8.5 billion of its debt.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Xykj689
via IFTTT

Read More

SC asks states, UTs to prepare action plan to implement guidelines for intensive care services

The Supreme Court has directed all states and Union Territories to develop realistic action plans for implementing minimum ICU standards. An expert-prepared guideline document will be shared, with a focus on identifying and prioritizing five essential manpower and equipment requirements. A compliance and monitoring mechanism is also mandated, with a three-week deadline for a final report.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/SFvyPDt
via IFTTT

Read More

Sun Pharma looks to outshine rival bids with $13 billion Organon offer

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the Indian drug giant into a global leader in branded and innovative medicines. Sun Pharma is competing with other major players for the US company. The deal, if successful, would see Organon merge with Sun Pharma.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oLTDs8N
via IFTTT

Read More